TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Visual analogue pain (VAS) score measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Weekly income
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Violence Experience
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Biochemically-confirmed 7-day point prevalence tobacco abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety changes in electrocardiogram (ECG)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with effective analgesic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle lipid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in At Risk Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline casual systolic blood pressure at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline 24-hour systolic blood pressure at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Optical clearing effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily Urticaria Activity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Rate of Growth (Slope) Estimated Based on GA Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sweating Assessed Using Gravimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in neuronal and white matter integrity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diabetes Self-Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Beck Depression Inventory-II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Snaith-Hamilton Pleasure Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of optimal functional PCI result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of poor functional PCI result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of optimal anatomical PCI result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of early supernormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screening capability for aneuploidy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of observed adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline In Forced Expiratory Volume In 1 Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Colonic geometric center at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ascending colonic emptying t1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric emptying of solids (T1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Continuous and non-invasive skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous and invasive core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial early diastolic velocity (E' velocity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preoxygenation Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Remission Rate (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CR With Incomplete Recovery (CRi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: end tidal concentration of desflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathological complete remission (pCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tear Lipid Layer Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheal and erythema size after skin prick test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in wheal size after challenge procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of patient control analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: complications related to opioids
Endpoint domain: Adverse events/effects
Primary endpoint: the requirement for additional analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Modified Psoriasis Area and Severity Index (PASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness and density of plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day and Night Mean Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Improved, Had no Change, and Worsened
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melanocortin receptor expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum proteome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial changes in plasma insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postprandial changes in plasma glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postprandial changes in triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial changes in amino acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of ED visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of patients with diagnostic potential of 18F-FDG PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic venous thromboembolic event
Endpoint domain: Adverse events/effects
Primary endpoint: Death related to PE
Endpoint domain: Mortality/survival
Primary endpoint: Asymptomatic DVT of the lower limbs detected by CUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Subclinical myocardial inflammatory burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUC-24 of furosemide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sodium excretion in the urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of H. pylori in dental plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum drug plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total area under the plasma concentration-time curve from time to administration to infinity (AUC0-infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural responses to positive and negative valence emotional faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural responses to positive and negative valence scenes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in blood oxytocin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Success rates of diagnostic biliary cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Success rates of deep biliary cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence and severity of any drug-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with abnormal clinical laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Epstein-Barr virus (EBV) viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity and specificity for identifying SUI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of asymptomatic carotid stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: prevalence of abdominal aortic aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Survival Without Evidence of Chronic Pulmonary Insufficiency of Prematurity
Endpoint domain: Mortality/survival
Primary endpoint: Pressure injury stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Macula lutea thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Geometric Mean Titers of Serum Bactericidal Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Fugl-Meyer Assessment Upper Extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HADS Questionnaire Combined Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reliability and reproducibility of intra oral light fluorescence camera
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quick DASH score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total cost of COPD
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of Treatment-associated Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Treatment-associated AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Children Who Maintain HIV-1 Plasma RNA Less Than 400 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Children Who Maintain HIV-1 Plasma RNA Less Than 40 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of surgeries done under general anaesthesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of GIM lesions regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-household transmission of poliovirus
Endpoint domain: Adverse events/effects
Primary endpoint: Intra-household transmission of poliovirus
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experience a Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with clinical significant effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cessation of Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Oral Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of pharyngeal residue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: De Jong Gierveld Loneliness Scale (DJGLS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of nosocomial ventilator-associated pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Change in forced expiratory volume in the first second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of event free survival
Endpoint domain: Mortality/survival
Primary endpoint: rate of dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: rate of intolerable refractory immune mediated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Evening Glucose Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute limb StO2 at limb perfusion pressures ≤ 30 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control corrected limb StO2 at limb perfusion pressures ≤ 30 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swallowing frequency of saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swallowing quality of saliva (speed of laryngeal elevation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swallowing quality of saliva (Range of movement of laryngeal elevation during swallowing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swallowing quality of saliva (time of pharyngeal closure during swallowing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in swallowing quality of saliva (pumping jaw movements before swallowing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Premature Infant Pain Profile (PIPP) scale rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with deficiencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial FGF21 plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cardiovascular responses to stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Insulin sensitivity and resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lipids and lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: R- and S-warfarin plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical function from baseline as assessed by the NIH stroke scale at three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical function from baseline as assessed by the NIH stroke at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical function as assessed by Barthel Scale compared to baseline at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life after acute pancreatitis
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Liver related Death
Endpoint domain: Mortality/survival
Primary endpoint: Device Fall-Offs
Endpoint domain: Adverse events/effects
Primary endpoint: Skin Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: mood and anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Tolerated Dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hematological Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Biochemical Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With No Cells Observed Following Slit Lamp Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Study Eye Central Retinal Thickness (CRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross level healing of naso-septal flap donor sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microscopic level healing of naso-septal flap donor sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective nasal symptoms following endoscopic skull based surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total work performed on progressive task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montgomery Åsberg Depression Rating Scale 10-item version (MADRS-10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Schedule-limiting toxicities (SLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in sedentary behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection rate of residual/refractory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year Overall Survival
Endpoint domain: Mortality/survival
Primary endpoint: Depersonalisation score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Detection rate of adenomas and serrated lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Uptake of genetic counselling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number and Percentage of Patients With Adverse Events of Special Interest
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in Eating Disorders Diagnostic Interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory Muscles Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in BODE index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAM-D score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitudes of decelerations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitudes of jerks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Completed Follow up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction of symptoms of cognitive disorders measured by CANTAB test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of symptoms of cognitive disorders measured by FAS test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of symptoms of cognitive disorders measured by DemTect test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuroimaging parameters derived from volumetry, DTI and rs fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vertical transmission rate from mother to child
Endpoint domain: Mortality/survival
Primary endpoint: Changes in short-time memory function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceived changes in capability assessed by input from care giver or family member
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in the Weekly Mean of the 24-Hour Average Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of in-ED hearing screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater Agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Responder Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving JIA ACR30 Response With Absence of Fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of congenital CMV infection in neonates with failed hearing screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of congenital CMV infection in neonates who are SGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants Reporting Solicited Injection-Site Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Solicited Systemic Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in Physical Activity/Step Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events associated with technical aspects of the operation
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Major Adverse Events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Responding to Weekly Text Message Surveys
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of Intervention Participants Completing Intervention Activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Tmax (Hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t (ng.h/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf (ng.h/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of RDT test-negative patients prescribed antimalarial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention